Privia Health (PRVA) Net Income towards Common Stockholders (2020 - 2026)

Privia Health's Net Income towards Common Stockholders history runs 7 years deep, the most recent figure standing at $3.7 million for Q1 2026.

• On a quarterly basis, Net Income towards Common Stockholders fell 38.67% year-over-year to $3.7 million in Q1 2026; TTM through Mar 2026 was $27.3 million, a 36.14% increase from a year earlier, with the FY2025 full-year figure at $29.7 million, up 74.41% from the prior year.
• Net Income towards Common Stockholders slipped to $3.7 million in Q1 2026 per PRVA's latest filing, from $10.6 million in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at $16.8 million in Q4 2022 and bottomed at -$18.1 million in Q1 2022.
• The 5-year median for Net Income towards Common Stockholders is $4.7 million (2024), against an average of $3.5 million.
• Across the five-year window, Net Income towards Common Stockholders tumbled 422.06% in 2022 and jumped 1062.82% in 2023, its largest moves.
• Year by year, Net Income towards Common Stockholders stood at $16.8 million in 2022, then plunged by 86.47% to $2.3 million in 2023, then soared by 137.19% to $5.4 million in 2024, then surged by 96.16% to $10.6 million in 2025, then tumbled by 64.95% to $3.7 million in 2026.
• Per Business Quant, the three latest PRVA Net Income towards Common Stockholders figures stand at $3.7 million (Q1 2026), $10.6 million (Q4 2025), and $9.8 million (Q3 2025).